abstract |
Provided herein are stable peptide analogs of the native alpha-melanocyte stimulating hormone (a-MSH) having selectivity for the melanocortin 1 receptor (MClR). Also provided herein are pharmaceutical preparations of the a-MSH peptide analogs, as well as methods of using these analogs in the treatment of medical and veterinary conditions involving MClR. |